LUNG AND PROSTATE CANCER (2)

Dr Bwayo Dennis

Prostate cancer is the second most common cancer among men in Uganda and the second most common globally, with over 1.4 million new cases reported in 2020. The document summarizes local data from the Uganda Cancer Institute, detailing patient demographics, disease stage distribution, and primary treatment patterns. It reviews PSA screening thresholds, Gleason scoring, and the spectrum of management strategies including active surveillance, surgery, radiotherapy, and hormonal therapy. Prognostic indicators such as Gleason score, PSA kinetics, and metastatic burden are discussed, along with preventive measures like 5α‑reductase inhibitors and targeted screening for high‑risk groups. The material is intended for facilitators leading educational sessions on prostate cancer care.